Table 2

Hippocampus and amygdala volumes in patients with major depression and participants in the control group at baseline and at 3-year follow-up

Volume, mL; patient status*Group; mean (and SD)
Patients, n = 30Controls, n = 30
BaselineFollow-upChange [95% CI]BaselineFollow-upChange [95% CI]
Hippocampus
Left total3.71 (0.34)3.78 (0.38)3.72 (0.37)3.76 (0.40)0.035 (0.24) [−0.053 to 0.12]
 In remission3.76 (0.37)3.86 (0.31)0.075 (0.24) [−0.018 to 0.17]
 Nonremitted3.65 (0.29)3.68 (0.45)
Right total3.85 (0.34)3.85 (0.33)3.82 (0.47)3.83 (0.42)0.01 (0.27) [−0.09 to 0.11]
 In remission3.76 (0.37)3.94 (0.25)0.006 (0.29) [−0.10 to 0.11]
 Nonremitted3.78 (0.33)3.73 (0.39)
Amygdala
Left total1.47 (0.25)1.43 (0.27)1.39 (0.21)1.37 (0.22)−0.02 (0.25) [−0.12 to 0.07]
 In remission1.47 (0.19)1.48 (0.28)−0.02 (0.25) [−0.12 to 0.07]
 Nonremitted1.48 (0.32)1.37 (0.26)
Right total1.56 (0.30)1.54 (0.27)1.45 (0.28)1.49 (0.25)−0.03 (0.22) [−0.11 to 0.06]
 In remission1.59 (0.30)1.61 (0.30)−0.04 (0.23) [−0.13 to 0.05]
 Nonremitted1.53 (0.31)1.45 (0.22)
  • CI = confidence interval; SD = standard deviation.

  • * We considered 17 patients to be in remission and 13 patients to be nonremitted.